Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interactions between rheumatoid arthritis synovial fibroblast migration and endothelial cells.
Zimmermann-Geller B, Köppert S, Kesel N, Hasseli R, Ullrich S, Lefèvre S, Frommer K, Gehrke T, Schönburg M, Rehart S, Schumacher U, Müller-Ladner U, Neumann E. Zimmermann-Geller B, et al. Among authors: hasseli r. Immunol Cell Biol. 2019 Feb;97(2):178-189. doi: 10.1111/imcb.12208. Epub 2018 Nov 2. Immunol Cell Biol. 2019. PMID: 30252968
The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis.
Neumann E, Hasseli R, Lange U, Müller-Ladner U. Neumann E, et al. Among authors: hasseli r. Curr Pharm Biotechnol. 2018;19(15):1182-1188. doi: 10.2174/1389201020666190102150216. Curr Pharm Biotechnol. 2018. PMID: 30605055 Review.
The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts.
Diller M, Frommer K, Dankbar B, Tarner I, Hülser ML, Tsiklauri L, Hasseli R, Sauerbier M, Pap T, Rehart S, Müller-Ladner U, Neumann E. Diller M, et al. Among authors: hasseli r. Arthritis Res Ther. 2019 Jun 10;21(1):144. doi: 10.1186/s13075-019-1926-7. Arthritis Res Ther. 2019. PMID: 31182152 Free PMC article.
Free Fatty Acids in Bone Pathophysiology of Rheumatic Diseases.
Frommer KW, Hasseli R, Schäffler A, Lange U, Rehart S, Steinmeyer J, Rickert M, Sarter K, Zaiss MM, Culmsee C, Ganjam G, Michels S, Müller-Ladner U, Neumann E. Frommer KW, et al. Among authors: hasseli r. Front Immunol. 2019 Dec 3;10:2757. doi: 10.3389/fimmu.2019.02757. eCollection 2019. Front Immunol. 2019. PMID: 31849953 Free PMC article.
[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
Schmeiser T, Broll M, Dormann A, Fräbel C, Hermann W, Hudowenz O, Keil F, Müller-Ladner U, Özden F, Pfeiffer U, Saech J, Schwarting A, Stapfer G, Steinchen N, Storck-Müller K, Strunk J, Thiele A, Triantafyllias K, Wassenberg S, Wilden E, Hasseli R. Schmeiser T, et al. Among authors: hasseli r. Z Rheumatol. 2020 May;79(4):379-384. doi: 10.1007/s00393-020-00800-8. Z Rheumatol. 2020. PMID: 32303821 Free PMC article. German.
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci et al.
Schulze-Koops H, Krueger K, Vallbracht IV, Hasseli R, Skapenko A. Schulze-Koops H, et al. Among authors: hasseli r. Ann Rheum Dis. 2022 Aug 11;81(9):e185. doi: 10.1136/annrheumdis-2020-218686. Ann Rheum Dis. 2022. PMID: 32753421 No abstract available.
44 results